Aims and Scope
Expert Review of Pharmacoeconomics & Outcomes Research is a bimonthly peer-reviewed medical journal covering all aspects of pharmacoeconomics. It was established in 2001 and is published by Informa. The editor-in-chief is A. Bottomley (European Organisation for Research and Treatment of Cancer).
Key Metrics
3.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
60
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.89
5-Year SI
5-year SI
- N/A 2-year SI
- 0.9 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Health Policy
SJR
- Q2 Health Policy
- Q2 Pharmacology (medical)
- Q2 Medicine (miscellaneous)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.9
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
18%
4 to 6 months
57%
7 to 9 months
20%
Above 9 months
5%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Cancer
- Economic evaluation
- Multiple sclerosis
- Acute failure
- Etanercept
- Quality of life
- Drug discovery
- Psoriatic arthritis
- Cross-sectional study
- Breast cancer
- Antidepressant
- Indirect costs
- Nivolumab
- Systematic review
- Chemotherapy
- Rheumatoid arthritis
- Total hip arthroplasty
- Type 2 diabetes
- Cerebral palsy
- Pediatric gastroenterology
Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Expert Review of Pharmacoeconomics and Outcomes Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Secondary healthcare resource utilization and related costs associated with influenza-related hospital admissions in adult patients, England 2016 – 2020
- 16 Mar 25
- Expert Review of Pharmacoeconomics & Outcomes Research
-
Full paper
Content and cost of waste pharmaceuticals collected by pharmacies for disposal
- 16 Mar 25
- Expert Review of Pharmacoeconomics & Outcomes Research
-
Full paper
Cost-effectiveness of atezolizumab plus Bevacizumab as first-line therapy for metastatic renal cell carcinoma
- 25 Nov 24
- Expert Review of Pharmacoeconomics & Outcomes Research
-
Full paper
Pharmacovigilance and outcomes: experience from Saudi Arabia narrative review
- 25 Nov 24
- Expert Review of Pharmacoeconomics & Outcomes Research
-
Full paper
Cost-effectiveness analysis of lorlatinib and crizotinib in the first-line treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer
- 10 Nov 24
- Expert Review of Pharmacoeconomics & Outcomes Research
-
Full paper
Costs for global guideline-based diagnosis of mucormycosis in patients with neutropenia, hematopoietic stem cell, or solid organ transplantation – a perspective of the German healthcare system
- 10 Nov 24
- Expert Review of Pharmacoeconomics & Outcomes Research
Scite analysis
Powered by scite_
2.1k articles received 26.1k citations see all
- 739 Supporting
- 24,460 Mentioning
- 76 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 6 Corrections
- 4 Errata
- 0 Expression of Concern
FAQs
How long has Expert Review of Pharmacoeconomics and Outcomes Research been actively publishing?
Expert Review of Pharmacoeconomics and Outcomes Research has been in operation since 2001 till date.
What is the publishing frequency of Expert Review of Pharmacoeconomics and Outcomes Research ?
Expert Review of Pharmacoeconomics and Outcomes Research published with a Bi-monthly frequency.
How many articles did Expert Review of Pharmacoeconomics and Outcomes Research publish last years ?
In 2023, Expert Review of Pharmacoeconomics and Outcomes Research published 130 articles.
What is the eISSN & pISSN for Expert Review of Pharmacoeconomics and Outcomes Research ?
For Expert Review of Pharmacoeconomics and Outcomes Research,eISSN is 1744-8379 and pISSN is1473-7167.
What is Citescore for Expert Review of Pharmacoeconomics and Outcomes Research ?
Citescore for Expert Review of Pharmacoeconomics and Outcomes Research is 3.4.
What is H index for Expert Review of Pharmacoeconomics and Outcomes Research ?
H index for Expert Review of Pharmacoeconomics and Outcomes Research is 60.
What is SNIP score for Expert Review of Pharmacoeconomics and Outcomes Research ?
SNIP score for Expert Review of Pharmacoeconomics and Outcomes Research is 0.9.
What is the SJR for Expert Review of Pharmacoeconomics and Outcomes Research ?
SJR for Expert Review of Pharmacoeconomics and Outcomes Research is Q2.
Who is the publisher of Expert Review of Pharmacoeconomics and Outcomes Research ?
TAYLOR & FRANCIS LTD is the publisher of Expert Review of Pharmacoeconomics and Outcomes Research.